EE200100193A - 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises - Google Patents
3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmisesInfo
- Publication number
- EE200100193A EE200100193A EEP200100193A EEP200100193A EE200100193A EE 200100193 A EE200100193 A EE 200100193A EE P200100193 A EEP200100193 A EE P200100193A EE P200100193 A EEP200100193 A EE P200100193A EE 200100193 A EE200100193 A EE 200100193A
- Authority
- EE
- Estonia
- Prior art keywords
- indan
- imidazol
- ylmethyl
- intraspinal
- intra
- Prior art date
Links
- VTZPAJGVRWKMAG-UHFFFAOYSA-N 3-(1h-imidazol-5-ylmethyl)-2,3-dihydro-1h-inden-5-ol Chemical compound C12=CC(O)=CC=C2CCC1CC1=CN=CN1 VTZPAJGVRWKMAG-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000036592 analgesia Effects 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010002091 Anaesthesia Diseases 0.000 abstract 1
- 206010039897 Sedation Diseases 0.000 abstract 1
- 230000037005 anaesthesia Effects 0.000 abstract 1
- 238000001949 anaesthesia Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000036280 sedation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10198698P | 1998-09-28 | 1998-09-28 | |
| PCT/FI1999/000793 WO2000018400A1 (en) | 1998-09-28 | 1999-09-27 | Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100193A true EE200100193A (et) | 2002-08-15 |
Family
ID=22287519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100193A EE200100193A (et) | 1998-09-28 | 1999-09-27 | 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6495584B1 (et) |
| EP (1) | EP1117399B1 (et) |
| JP (1) | JP4647785B2 (et) |
| KR (1) | KR100646811B1 (et) |
| CN (1) | CN1320034A (et) |
| AT (1) | ATE288753T1 (et) |
| AU (1) | AU756104B2 (et) |
| BG (1) | BG105469A (et) |
| CA (1) | CA2345521C (et) |
| CZ (1) | CZ299918B6 (et) |
| DE (1) | DE69923698T2 (et) |
| DK (1) | DK1117399T3 (et) |
| EA (1) | EA003216B1 (et) |
| EE (1) | EE200100193A (et) |
| ES (1) | ES2237205T3 (et) |
| HK (1) | HK1039751A1 (et) |
| HU (1) | HU227634B1 (et) |
| IL (2) | IL141680A0 (et) |
| NO (1) | NO330436B1 (et) |
| NZ (1) | NZ510233A (et) |
| PL (1) | PL346908A1 (et) |
| SK (1) | SK3812001A3 (et) |
| UA (1) | UA61152C2 (et) |
| WO (1) | WO2000018400A1 (et) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001000192A2 (en) * | 1999-06-25 | 2001-01-04 | Orion Corporation | Method of administering an imidazole derivative to obtain analgesia |
| FI20022159A0 (fi) | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
| CN116617205A (zh) * | 2023-07-07 | 2023-08-22 | 生物岛实验室 | 乙酰丙酸茚满酯在预防和/或治疗肌肉萎缩相关疾病中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI894911A0 (fi) | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| US5801188A (en) | 1997-01-08 | 1998-09-01 | Medtronic Inc. | Clonidine therapy enhancement |
-
1999
- 1999-09-27 DK DK99969677T patent/DK1117399T3/da active
- 1999-09-27 CA CA002345521A patent/CA2345521C/en not_active Expired - Lifetime
- 1999-09-27 EE EEP200100193A patent/EE200100193A/et unknown
- 1999-09-27 NZ NZ510233A patent/NZ510233A/en not_active IP Right Cessation
- 1999-09-27 EP EP99969677A patent/EP1117399B1/en not_active Expired - Lifetime
- 1999-09-27 IL IL14168099A patent/IL141680A0/xx active IP Right Grant
- 1999-09-27 HU HU0103864A patent/HU227634B1/hu unknown
- 1999-09-27 EA EA200100405A patent/EA003216B1/ru not_active IP Right Cessation
- 1999-09-27 ES ES99969677T patent/ES2237205T3/es not_active Expired - Lifetime
- 1999-09-27 AU AU59860/99A patent/AU756104B2/en not_active Expired
- 1999-09-27 PL PL99346908A patent/PL346908A1/xx not_active Application Discontinuation
- 1999-09-27 HK HK02101329.8A patent/HK1039751A1/zh unknown
- 1999-09-27 CZ CZ20010933A patent/CZ299918B6/cs not_active IP Right Cessation
- 1999-09-27 US US09/787,886 patent/US6495584B1/en not_active Expired - Lifetime
- 1999-09-27 SK SK381-2001A patent/SK3812001A3/sk unknown
- 1999-09-27 JP JP2000571918A patent/JP4647785B2/ja not_active Expired - Lifetime
- 1999-09-27 AT AT99969677T patent/ATE288753T1/de not_active IP Right Cessation
- 1999-09-27 WO PCT/FI1999/000793 patent/WO2000018400A1/en not_active Ceased
- 1999-09-27 DE DE69923698T patent/DE69923698T2/de not_active Expired - Lifetime
- 1999-09-27 KR KR1020017003511A patent/KR100646811B1/ko not_active Expired - Lifetime
- 1999-09-27 CN CN99811480A patent/CN1320034A/zh active Pending
- 1999-09-27 UA UA2001042926A patent/UA61152C2/uk unknown
-
2001
- 2001-02-27 IL IL141680A patent/IL141680A/en not_active IP Right Cessation
- 2001-03-26 NO NO20011545A patent/NO330436B1/no not_active IP Right Cessation
- 2001-04-25 BG BG105469A patent/BG105469A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7834053B2 (en) | Medicinal compositions improving brain function and method for improving brain function | |
| CY1111088T1 (el) | Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση | |
| ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
| ATE361077T1 (de) | Indanylderivate zur behandlung von atemwegserkrankungen | |
| TNSN04246A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
| EA200700232A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| EE200300106A (et) | Farmatseutiline kompositsioon kui süsteemne analgeetikum | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
| WO2009009501A3 (en) | Non-basic melanin concentrating hormone receptor-1 antagonists and methods | |
| NO20055655D0 (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
| KR970025615A (ko) | 암 전이 억제제 | |
| MX2007006637A (es) | Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa. | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| WO1994016689A1 (fr) | Composition officinale analgesique | |
| PL346908A1 (en) | Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration | |
| BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| MXPA05008711A (es) | Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico. | |
| SE9900190D0 (sv) | New compounds | |
| MXPA04010658A (es) | Tratamiento de dolor con ifenprodil. | |
| PT1082116E (pt) | Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento | |
| Rorarius et al. | The effect of diclofenac and ketoprofen on halothane MAC in rabbit | |
| MXPA02007454A (es) | Compuestos utiles para tratamiento o prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor. | |
| RU2002121654A (ru) | Способ обезболивания при операциях на конечностях | |
| WO2001000192A3 (en) | Method of administering an imidazole derivative to obtain analgesia |